Location History:
- Euskirchen, DE (2015 - 2023)
- Cologne, DE (2022 - 2023)
Company Filing History:
Years Active: 2015-2025
Title: Timo Gleissner: Innovator in Cell Treatment Technologies
Introduction
Timo Gleissner is a prominent inventor based in Euskirchen, Germany, known for his significant contributions to the field of cell treatment technologies. With a total of 14 patents to his name, he has made remarkable advancements in methods and devices for the treatment of adherent cells.
Latest Patents
One of his latest patents is a method and device for uniformly treating adherent cells. This innovative method involves subjecting adherent cells to at least one electric field generated by applying a voltage to at least two active electrodes. The design includes at least three electrodes, with at least two being active when the voltage is applied to create a first electric field. Additionally, a second electric field is generated, utilizing at least one of the previously active electrodes as a potential-free electrode during the voltage application. The device associated with this method comprises at least three electrodes connected to a voltage source through multiple switching devices, allowing for efficient and uniform treatment of adherent cells.
Another notable patent is focused on end-to-end cell therapy automation. This automated method produces genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, using a fully-enclosed cell engineering system. This advancement represents a significant step forward in the field of cell therapy.
Career Highlights
Throughout his career, Timo Gleissner has worked with notable companies, including Lonza Cologne GmbH and Lonza Walkersville, Inc. His experience in these organizations has contributed to his expertise in cell treatment technologies and innovation.
Collaborations
Timo has collaborated with esteemed colleagues such as Andreas Heinze and Ludger Altrogge, further enhancing his work in the field.
Conclusion
Timo Gleissner's innovative contributions to cell treatment technologies and his extensive patent portfolio highlight his role as a leading inventor in this domain. His work continues to influence advancements in cell therapy and treatment methods.